Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma

ClinicalTrials.gov ID: NCT07163273

Public ClinicalTrials.gov record NCT07163273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 6, 2026, 9:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT07163273
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Northwell Health; Other
Enrollment: 41 participants

Conditions and interventions

Conditions

Pancreatic Ductal Adenocarcinoma

Interventions

Gemcitabine plus nab-Paclitaxel (GnP) Drug
NALIRIFOX Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 19, 2025
Primary completion: Jun 19, 2027
Completion: Jun 19, 2027
Last update posted: Mar 17, 2026

2025 – 2027

United States locations

U.S. sites: 7
U.S. states: 1
U.S. cities: 6

Facility	City	State	ZIP	Site status
Imbert Cancer Center	Bay Shore	New York	11706	Recruiting
Northern Westchester Cancer Center	Mount Kisco	New York	10549	Recruiting
Long Island Jewish Medical Center	New Hyde Park	New York	11040	Recruiting
Zuckerberg Cancer Center	New Hyde Park	New York	11042	Recruiting
Manhattan Eye, Ear and Throat Hospital	New York	New York	10065	Recruiting
NHPP Medical Oncology at Rego Park	Rego Park	New York	11374	Recruiting
Phelps Cancer Center	Sleepy Hollow	New York	10591	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07163273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 17, 2026 · Synced May 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07163273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →